Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;24(10):1900147.
doi: 10.2807/1560-7917.ES.2019.24.10.1900147.

Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018

Affiliations

Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018

David W Eyre et al. Euro Surveill. 2019 Mar.

Abstract

We describe detection in the United Kingdom (UK) of the drug-resistant Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate azithromycin resistance. Two female patients developed infection following contact with UK-resident men from the same sexual network linked to travel to Ibiza, Spain. One case failed treatment with ceftriaxone, and azithromycin and gentamicin, before successful treatment with ertapenem. Both isolates had indistinguishable whole-genome sequences. Urgent action is essential to contain this drug-resistant strain.

Keywords: antimicrobial resistance; antimicrobial treatment; gonorrhoeae; treatment failure; whole-genome sequencing.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure 1
Figure 1
Ceftriaxone-resistant Neisseria gonorrhoeae isolates (n=15), including from Case 1 and Case 2, United Kingdom, 2018
Figure 2
Figure 2
Time-dated Bayesian phylogeny of Neisseria gonorrhoeae FC428 clone cases and epidemiological details, 2015–2019 (n = 10)

Comment in

References

    1. Nakayama S, Shimuta K, Furubayashi K, Kawahata T, Unemo M, Ohnishi M. New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan. Antimicrob Agents Chemother. 2016;60(7):4339-41. 10.1128/AAC.00504-16 - DOI - PMC - PubMed
    1. Yahara K, Nakayama S-I, Shimuta K, Lee KI, Morita M, Kawahata T, et al. Genomic surveillance of Neisseria gonorrhoeae to investigate the distribution and evolution of antimicrobial-resistance determinants and lineages. Microb Genom. 2018;4(8): Epub ahead of print. 10.1099/mgen.0.000205 - DOI - PMC - PubMed
    1. Lahra MM, Martin I, Demczuk W, Jennison AV, Lee KI, Nakayama SI, et al. Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain. Emerg Infect Dis. 2018;24(4). 10.3201/eid2404.171873 - DOI - PMC - PubMed
    1. Lefebvre B, Martin I, Demczuk W, Deshaies L, Michaud S, Labbé AC, et al. Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017. Emerg Infect Dis. 2018;24(2):381-3. 10.3201/eid2402.171756 - DOI - PMC - PubMed
    1. Terkelsen D, Tolstrup J, Johnsen CH, Lund O, Larsen HK, Worning P, et al. Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017. Euro Surveill. 2017;22(42):1273. 10.2807/1560-7917.ES.2017.22.42.17-00659 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources